Pharmacy M&A Valuation Segment Report
Comparable Transactions / Precedent Deals
 
Excel spreadsheet with Scope Research's pharmacy M&A valuation data and benchmarking tools. Transactions are segmented by type, which include specialty, retail, institutional and compounding pharmacies, as well as pharmacy -related services and infusion therapy.
 
75 transactions with revenue or EBITDA multiples (since 2010)
62 of these deals have reported EBITDA Multiples
Last updated 12/4/24
 
Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented. 

Reach out to will@scoperesearch.co for more information.

All transactions included in the Scope Research healthcare M&A databases are meticulously researched and sourced from public documentation. Our internal records include an audit trail of links to our sources, which include:
 
Fairness opinions
SEC filings
Press releases
Bond market research
Medicare cost reports
CON filings (FOIA)
Form 990s
Public audits
AG reports
Insurance department filings